Mycobacterium Citations List: November 2022
Literature Citations
1. Glycosylated Flavonoid Compounds as Potent Cyp121 Inhibitors of Mycobacterium tuberculosis. Bajrai, L.H., A.M. Khateb, M.M. Alawi, H.R. Felemban, A.A. Sindi, V.D. Dwivedi, and E.I. Azhar. Biomolecules, 2022. 12(10): 1356. PMID[36291570]. PMCID[PMC9599785].
[PubMed]. TB_11_2022.
2. In Silico, in Vitro Antimicrobial and Antimycobacterial Evaluation of Newly Synthesized 2r, 6c-Diaryl-3t-methylpiperidin-4-one arylsulphonylhydrazones. Balasubramaniyan, M., V. Vimalraj, M. Philip Jacob Kizhakedathil, and K. Pandiarajan. Bioorganic Chemistry, 2022. 128: 106033. PMID[35926427].
[PubMed]. TB_11_2022.
3. Antimycobacterial Activity of Rosmarinus officinalis (Rosemary) Extracted by Deep Eutectic Solvents. Dheyab, A.S., M.Q. Kanaan, N.A. Hussein, M.K. AlOmar, S.F. Sabran, and M.F. Abu Bakar. Separations, 2022. 9(10): 271. ISI[000875987500001].
[WOS]. TB_11_2022.
4. Nitrothiazole-Thiazolidinone Hybrids: Synthesis and in Vitro Antimicrobial Evaluation. Hart, D., L.J. Legoabe, O.J. Jesumoroti, A. Jordaan, D.F. Warner, R. Steventon, and R.M. Beteck. Chemistry & Biodiversity, 2022. 19(11): e202200729. PMID[36102043].
[PubMed]. TB_11_2022.
5. Evybactin Is a DNA Gyrase Inhibitor That Selectively Kills Mycobacterium tuberculosis. Imai, Y., G. Hauk, J. Quigley, L. Liang, S. Son, M. Ghiglieri, M.F. Gates, M. Morrissette, N. Shahsavari, S. Niles, D. Baldisseri, C. Honrao, X. Ma, J.J. Guo, J.M. Berger, and K. Lewis. Nature Chemical Biology, 2022. 18(11): p. 1236-1244. PMID[35996001].
[PubMed]. TB_11_2022.
6. Design, Synthesis and Biological Evaluation of (Quinazoline 4-yloxy)acetamide and (4-Oxoquinazoline-3(4H)yl)acetamide Derivatives as Inhibitors of Mycobacterium tuberculosis BD Oxidase. Kumar, A., N. Kumari, S. Bhattacherjee, U. Venugopal, S. Parwez, M.I. Siddiqi, M.Y. Krishnan, and G. Panda. European Journal of Medicinal Chemistry, 2022. 242: 114639. PMID[35973312].
[PubMed]. TB_11_2022.
7. Design, Synthesis and Computational Approach to Study Novel Pyrrole Scaffolds as Active Inhibitors of Enoyl ACP Reductase (InhA) and Mycobacterium tuberculosis Antagonists. Kumar, S.R.P., I.A. Shaikh, M.H. Mahnashi, M.A. Alshahrani, S.R. Dixit, V.H. Kulkarni, C. Lherbet, A.K. Gadad, T.M. Aminabhavi, and S.D. Joshi. Journal of the Indian Chemical Society, 2022. 99(11): 10067. ISI[000878738000002].
[WOS]. TB_11_2022.
8. Synthesis of Capuramycin and its Analogues Via a Ferrier-type I Reaction and their Biological Evaluation. Kusaka, S., K. Yamamoto, M. Shinohara, Y. Minato, and S. Ichikawa. Bioorganic & Medicinal Chemistry, 2022. 73: 117011. PMID[36191548].
[PubMed]. TB_11_2022.
9. Syntheses and Studies of Deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with Potent Anti-tuberculosis Activity and Improved Metabolic Properties. Liu, R., K. Marshall, R. Ma, K. Lien Thi Pham, G. Shetye, Z. Liu, S. Cho, H. Jeong, S.G. Franzblau, G.C. Moraski, and M.J. Miller. Bioorganic Chemistry, 2022. 128: 106074. PMID[35987188].
[PubMed]. TB_11_2022.
10. DNA Binding, Antitubercular, Antibacterial and Anticancer Studies of Newly Designed Piano-stool Ruthenium(II) Complexes. Navale, G., S. Singh, S. Agrawal, C. Ghosh, A. Roy Choudhury, P. Roy, D. Sarkar, and K. Ghosh. Dalton Transactions, 2022. 51(42): p. 16371-16382. PMID[36250384].
[PubMed]. TB_11_2022.
11. Oligoglycol Carbonate Prodrugs of 5-Modified 2 '-Deoxyuridines: Synthesis and Antibacterial Activity. Negrya, S.D., M.V. Jasko, D.A. Makarov, I.L. Karpenko, P.N. Solyev, V.O. Chekhov, O.V. Efremenkova, B.F. Vasilieva, T.A. Efimenko, S.N. Kochetkov, and L.A. Alexandrova. Mendeleev Communications, 2022. 32(4): p. 433-435. ISI[000881672000002].
[WOS]. TB_11_2022.
12. Discovery of Substituted Benzyloxy-benzylamine Inhibitors of Acetyltransferase Eis and Their Anti-mycobacterial Activity. Pang, A.H., K.D. Green, N.T. Chandrika, A. Garzan, A. Punetha, S.Y.L. Holbrook, M.J. Willby, J.E. Posey, O.V. Tsodikov, and S. Garneau-Tsodikova. European Journal of Medicinal Chemistry, 2022. 242: 114698. PMID[36037791]. PMCID[PMC9481687].
[PubMed]. TB_11_2022.
13. Bioevaluation of Quinoline-4-carbonyl Derivatives of Piperazinyl-benzothiazinones as Promising Antimycobacterial Agents. Sahoo, S.K., S.N.R. Gajula, M.N. Ahmad, G. Kaul, S. Nanduri, R. Sonti, A. Dasgupta, S. Chopra, and V.M. Yaddanapudi. Archiv der Pharmazie, 2022. 355(11): e2200168. PMID[35876343].
[PubMed]. TB_11_2022.
14. Seven New Alkaloids Isolated from Marine Flavobacterium tenacibaculum discolor sv11. Wang, L., M. Marner, U. Mettal, Y. Liu, and T.F. Schäberle. Marine Drugs, 2022. 20(10): 620. PMID[36286444]. PMCID[PMC9605681].
[PubMed]. TB_11_2022.
15. Disulfiram Is Effective against Drug-resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model. Winters, C.G., R.M. Basnet, P.E. Faasuamalie, S.J. Shallom, A.M. Zelazny, S. Gupta, and K.N. Olivier. Antimicrobial Agents and Chemotherapy, 2022. 66(11): e0053922. PMID[36197094]. PMCID[PMC9664858].
[PubMed]. TB_11_2022.
16. Discovery of New Riminophenazine Analogues as Antimycobacterial Agents against Drug-resistant Mycobacterium tuberculosis. Zhao, X., Y. Mei, Z. Guo, S. Si, X. Ma, Y. Li, Y. Li, and D. Song. Bioorganic Chemistry, 2022. 128: 105929. PMID[35701239].
[PubMed]. TB_11_2022.
17. Sulforaphane Kills Mycobacterium tuberculosis H37ra and Mycobacterium smegmatis mc2155 through a Reactive Oxygen Species Dependent Mechanism. Zhao, Y., S. Shang, Y. Song, T. Li, M. Han, Y. Qin, M. Wei, J. Xi, and B. Tang. Journal of Microbiology, 2022. 60(11): p. 1095-1105. PMID[36048328].
[PubMed]. TB_11_2022.
Literature Citations
This month, no relevant Mycobacterium patents were identified.